|
|
|
(JDM-002) Insulin Receptor Knockout Mice
| |
Ronald Kahn, M.D.
Select:
|
|
(JDM-004) Insulin Receptor Substrate Knockout Mice
| |
Ronald Kahn, M.D.
Morris White Ph.D.
Select:
|
|
(JDP-013, 021, 022) Insulin Receptor Substrate Portfolio
| |
Ronald Kahn, M.D.
Morris White Ph.D.
et al.
|
|
(JDP-015) Diabetogene RAD
|
(JDP-045) Methods for Identifying Compounds for Treatment of Insulin Resistance
| |
Steven Shoelson, M.D., Ph.D.
et al.
|
|
(JDP-061) Methods of Modulating Angiogenesis
| |
George Liang King, M.D.
et al.
|
|
(JDP-072) Insulin Related Transcription Factor
|
(JDP-093) SKN-1 and Oxidative Stress Resistance
| |
Keith Blackwell, M.D., Ph.D.
|
|
(JDP-094) ARNT: A Novel Target for Treatment of Diabetes
|
(JDP-107) ARNT2: A Novel Target for Diabetes
|
(JDP-129) Improving Glycemic Control
| |
Mary Elizabeth Patti, M.D.
|
|
